Anti-Signal Recognition Particle Myopathy in the First Decade of Life

被引:23
|
作者
Suzuki, Shigeaki [1 ]
Ohta, Masayasu [2 ]
Shimizu, Yuko [3 ]
Hayashi, Yukiko K. [4 ]
Nishino, Ichizo [4 ]
机构
[1] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Toride Kyodo Gen Hosp, Dept Pediat, Ibaraki, Japan
[3] Natl Ctr Hosp Neurol & Psychiat, Dept Pediat Neurol, Tokyo, Japan
[4] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan
关键词
IDIOPATHIC INFLAMMATORY MYOPATHIES; AUTOANTIBODIES; MYOSITIS; HETEROGENEITY; POLYMYOSITIS; ANTIBODIES;
D O I
10.1016/j.pediatrneurol.2011.04.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autoantibodies to signal recognition particle have been associated with juvenile and adult-onset necrotizing myopathy. However, only a few teenage patients with anti-signal recognition particle myopathy have been reported, and to date, to our knowledge, no patient younger than 10 years has been documented. We describe 2 Japanese girls with anti-signal recognition particle myopathy who developed symptoms from the ages of 5 and 9 years, respectively. Both patients had progressive muscle weakness and atrophy without myalgia. Facioscapulohumeral muscular dystrophy was initially suspected because of asymmetric shoulder girdle muscle involvement in one patient, and limb girdle muscular dystrophy due to proximal limb muscle weakness in the other. There were no extramuscular manifestations, including fever or arthritis. Serum creatine kinase levels were elevated to 2,467-4,629 IU/L Results of muscle biopsy revealed necrotizing myopathy with minimal to mild endomysial fibrosis but without inflammatory infiltrates. Immunosuppressive agents were not effective for muscle weakness, resulting in marked disability. Anti-signal recognition particle myopathy can occur in the first decade of life and should be included in the differential diagnosis for children with progressive limb girdle muscle weakness and high creatine kinase levels. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 116
页数:3
相关论文
共 50 条
  • [31] Anti-Signal Recognition Particle Autoantibody ELISA Development and Validation: Utility in Patients with Necrotizing Myopathy.
    Aggarwal, Rohit
    Oddis, Chester V.
    Goudeau, Danielle
    Stephans, Chad
    Fertig, Noreen
    Qi Zengbiao
    Koontz, Diane
    Levesque, Marc C.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S827 - S827
  • [32] Correlation of Anti-Signal Recognition Particle Autoantibody Levels With Creatine Kinase Activity in Patients With Necrotizing Myopathy
    Benveniste, Olivier
    Drouot, Laurent
    Jouen, Fabienne
    Charuel, Jean-Luc
    Bloch-Queyrat, Coralie
    Behin, Anthony
    Amoura, Zahir
    Marie, Isabelle
    Guiguet, Marguerite
    Eymard, Bruno
    Gilbert, Daniele
    Tron, Francois
    Herson, Serge
    Musset, Lucile
    Boyer, Olivier
    ARTHRITIS AND RHEUMATISM, 2011, 63 (07): : 1961 - 1971
  • [33] Rheumatoid Arthritis Associated With Anti-Signal Recognition Particle Immune-Mediated Necrotizing Myopathy: A Case Report
    Belkhribchia, Mohamed Reda
    Lobrinus, Johannes Alexander
    Semlil, Lamyaa
    Chauveau, Nicolas
    Ajrinija, Abdelaziz
    Egervari, Kristof
    Ennhaili, Zine Elabidine
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2024, 12
  • [34] Clinical features and treatment outcome of four patients with anti-signal recognition particle antibody positive necrotizing myopathy
    Nomura, S.
    Ueno, A.
    Miyazaki, D.
    Kishida, D.
    Hineno, A.
    Shimojima, Y.
    Sekijima, Y.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 657 - 658
  • [35] Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy treated with ofatumumab
    Wen, Chunbei
    Yang, Jie
    Wei, Dongsheng
    Xu, Changyou
    Yu, Ping
    Luo, Lijun
    RHEUMATOLOGY, 2024, 63 (02)
  • [36] Marked Efficacy of a Therapeutic Strategy in a Patient With Necrotizing Myopathy Associated With Anti-signal Recognition Particle (SRP) Autoantibodies
    Almaghrabi, Murouj
    Almatrafi, Shahad B.
    Alzahrani, Asma
    Alharbi, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [37] Rituximab for patients with myopathy associated with anti-signal recognition particle antibodies: comment on the article by Valiyil et al
    Deligny, Christophe
    Goeb, Vincent
    Dueymes, Maryvonne
    Kahn, Valentine
    Dehlinger, Veronique
    Baptiste, Georges Jean
    Amarof, Khadija
    Arfi, Serge
    ARTHRITIS CARE & RESEARCH, 2011, 63 (03) : 460 - 460
  • [38] Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies
    Ge, Yongpeng
    Yang, Hanbo
    Xiao, Xinyue
    Liang, Lin
    Lu, Xin
    Wang, Guochun
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [39] Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies
    Yongpeng Ge
    Hanbo Yang
    Xinyue Xiao
    Lin Liang
    Xin Lu
    Guochun Wang
    BMC Pulmonary Medicine, 22
  • [40] Anti-signal recognition particle (SRP) Autoantibodies (Ab) in patients (pts) with and without idiopathic inflammatory myopathy (IIM).
    Kao, A
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S488 - S488